Clinical Trial Update: Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 clinical trial evaluating topotecan in combination with gemcitabine for platinum-resistant ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Topotecan (topotecan)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED